abstract |
The invention provides novel Diaryl Ether derivatives as beta2 adrenergic receptor agonists. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds. |